Haddad N - Search Results

1

Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial.

Neven P, Rugo HS, Tolaney SM, Iwata H, Toi M, Goetz MP, Kaufman PA, Lu Y, Haddad N, Hurt KC, Sledge GW Jr. Neven P, et al. Among authors: haddad n. Breast Cancer Res. 2021 Aug 23;23(1):87. doi: 10.1186/s13058-021-01463-2. Breast Cancer Res. 2021. PMID: 34425869 Free PMC article. Clinical Trial.

2

MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR⁺, HER2^--Advanced Breast Cancer.

Neven P, Johnston SRD, Toi M, Sohn J, Inoue K, Pivot X, Burdaeva O, Okera M, Masuda N, Kaufman PA, Koh H, Grischke EM, Conte P, Lu Y, Haddad N, Hurt KC, Llombart-Cussac A, Sledge GW. Neven P, et al. Among authors: haddad n. Clin Cancer Res. 2021 Nov 1;27(21):5801-5809. doi: 10.1158/1078-0432.CCR-20-4685. Epub 2021 Aug 10. Clin Cancer Res. 2021. PMID: 34376533

3

Abemaciclib plus fulvestrant in East Asian women with HR+, HER2- advanced breast cancer: Overall survival from MONARCH 2.

Toi M, Huang CS, Im YH, Sohn J, Zhang W, Sakaguchi S, Haddad N, van Hal G, Sledge GW Jr. Toi M, et al. Among authors: haddad n. Cancer Sci. 2023 Jan;114(1):221-226. doi: 10.1111/cas.15600. Epub 2022 Oct 12. Cancer Sci. 2023. PMID: 36168844 Free PMC article. Clinical Trial.

4

A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer.

Farhat FS, Temraz S, Kattan J, Ibrahim K, Bitar N, Haddad N, Jalloul R, Hatoum HA, Nsouli G, Shamseddine AI. Farhat FS, et al. Among authors: haddad n. Clin Breast Cancer. 2011 Dec;11(6):384-9. doi: 10.1016/j.clbc.2011.08.005. Epub 2011 Oct 10. Clin Breast Cancer. 2011. PMID: 21993011 Clinical Trial.

5

A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer.

Ghosn M, Aftimos P, Farhat FS, Kattan JG, Hanna C, Haddad N, Nasr F, Chahine G. Ghosn M, et al. Among authors: haddad n. Med Oncol. 2011 Dec;28 Suppl 1:S142-51. doi: 10.1007/s12032-010-9754-2. Epub 2010 Dec 7. Med Oncol. 2011. PMID: 21136213 Clinical Trial.

6

Budd-Chiari syndrome and heparin-induced thrombocytopenia in polycythemia vera: successful treatment with repeated TIPS and interferon alpha.

Akoum R, Mahfoud D, Ghaoui A, Haddad N, Mahfoud N, Farhat H, Khoury J. Akoum R, et al. Among authors: haddad n. J Cancer Res Ther. 2009 Oct-Dec;5(4):305-8. doi: 10.4103/0973-1482.59917. J Cancer Res Ther. 2009. PMID: 20160369 Free article.

7

Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer.

Ferguson RD, Gallagher EJ, Cohen D, Tobin-Hess A, Alikhani N, Novosyadlyy R, Haddad N, Yakar S, LeRoith D. Ferguson RD, et al. Among authors: haddad n. Endocr Relat Cancer. 2013 May 21;20(3):391-401. doi: 10.1530/ERC-12-0333. Print 2013 Jun. Endocr Relat Cancer. 2013. PMID: 23572162 Free PMC article.

8

Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia.

Gallagher EJ, Fierz Y, Vijayakumar A, Haddad N, Yakar S, LeRoith D. Gallagher EJ, et al. Among authors: haddad n. Oncogene. 2012 Jul 5;31(27):3213-22. doi: 10.1038/onc.2011.495. Epub 2011 Oct 31. Oncogene. 2012. PMID: 22037215 Free PMC article.

9

The Alia Camel of Jordan: a genetically distinct dromedary breed.

Haddad NJ, Al-Araishi MA, Awabdeh S, Patidar R, Bell R, Jawasreh K, Alhurani H, Elharbid LJ, Sweidan R, Al-Anaswah EN, Brake M, Sadder MT, Blanco OA, Sbeih L, Uduman M, Lakhani SA, Khokha MK, Weir A. Haddad NJ, et al. J Hered. 2025 Jan 6:esae076. doi: 10.1093/jhered/esae076. Online ahead of print. J Hered. 2025. PMID: 39761336

10

Modeling inactivation of non-proteolytic Clostridium botulinum type B spores in a plant-based fish alternative.

Champidou C, Ellouze M, Haddad N, Membré JM. Champidou C, et al. Among authors: haddad n. Front Microbiol. 2024 Dec 18;15:1509681. doi: 10.3389/fmicb.2024.1509681. eCollection 2024. Front Microbiol. 2024. PMID: 39744390 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

982 results

Search Page

Filters